Arcutis Biotherapeutics, Inc. - COMMON STOCK (ARQT)
CUSIP: 03969K108
Q3 2023 13F Holders as of 30 Sep 2023
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 123,454,843
- Total 13F shares
- 67,159,664
- Share change
- -3,130,955
- Total reported value
- $356,705,615
- Put/Call ratio
- 167%
- Price per share
- $5.31
- Number of holders
- 131
- Value change
- -$26,597,323
- Number of buys
- 72
- Number of sells
- 54
Quarterly Holders Quick Answers
What is CUSIP 03969K108?
CUSIP 03969K108 identifies ARQT - Arcutis Biotherapeutics, Inc. - COMMON STOCK in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03969K108:
Top shareholders of ARQT - Arcutis Biotherapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
7.5%
|
9,212,786
|
$87,797,848 | — | 30 Jun 2023 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
7%
|
8,684,232
|
$82,760,731 | — | 30 Jun 2023 | |
| STATE STREET CORP |
13F
|
Company |
4.2%
|
5,226,009
|
$49,803,866 | — | 30 Jun 2023 | |
| Rubric Capital Management LP |
13F
|
Company |
4%
|
4,884,530
|
$46,549,571 | — | 30 Jun 2023 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
3.5%
|
4,293,966
|
$40,921,495 | — | 30 Jun 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.4%
|
4,231,374
|
$40,324,995 | — | 30 Jun 2023 | |
| Polar Capital Holdings Plc |
13F
|
Company |
2.5%
|
3,127,777
|
$29,807,715 | — | 30 Jun 2023 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
2.4%
|
3,000,000
|
$28,590,000 | — | 30 Jun 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.1%
|
2,650,388
|
$25,258,197 | — | 30 Jun 2023 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1.9%
|
2,317,541
|
$22,086,166 | — | 30 Jun 2023 | |
| GW&K Investment Management, LLC |
13F
|
Company |
1.7%
|
2,062,683
|
$19,657,000 | — | 30 Jun 2023 | |
| ORBIMED ADVISORS LLC |
13F
3/4/5
|
Company · 10%+ Owner |
1.6%
|
1,914,479
|
$18,244,985 | — | 30 Jun 2023 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.3%
|
1,652,536
|
$15,748,668 | — | 30 Jun 2023 | |
| Holocene Advisors, LP |
13F
|
Company |
1.2%
|
1,440,036
|
$13,723,543 | — | 30 Jun 2023 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
1.1%
|
1,327,029
|
$12,646,586 | — | 30 Jun 2023 | |
| Pivotal bioVenture Partners Investment Advisor LLC |
13F
|
Company |
0.9%
|
1,105,309
|
$10,533,595 | — | 30 Jun 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.76%
|
937,447
|
$8,933,873 | — | 30 Jun 2023 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.71%
|
872,427
|
$8,314,229 | — | 30 Jun 2023 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.67%
|
832,540
|
$7,934,106 | — | 30 Jun 2023 | |
| Woodline Partners LP |
13F
|
Company |
0.65%
|
807,750
|
$7,697,858 | — | 30 Jun 2023 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.65%
|
800,000
|
$7,624,000 | — | 30 Jun 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.56%
|
694,321
|
$6,616,880 | — | 30 Jun 2023 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.41%
|
509,879
|
$4,859,151 | — | 30 Jun 2023 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.4%
|
499,922
|
$4,764,257 | — | 30 Jun 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.39%
|
485,978
|
$4,631,368 | — | 30 Jun 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.38%
|
465,653
|
$4,437,673 | — | 30 Jun 2023 | |
| AXA S.A. |
13F
|
Company |
0.36%
|
448,642
|
$4,275,558 | — | 30 Jun 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.33%
|
406,555
|
$3,874,469 | — | 30 Jun 2023 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.29%
|
363,415
|
$3,463,345 | — | 30 Jun 2023 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.27%
|
337,052
|
$3,212,105 | — | 30 Jun 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.27%
|
329,942
|
$3,144,347 | — | 30 Jun 2023 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.24%
|
293,047
|
$2,792,738 | — | 30 Jun 2023 | |
| AlphaCentric Advisors LLC |
13F
|
Company |
0.24%
|
292,500
|
$2,787,525 | — | 30 Jun 2023 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.22%
|
268,947
|
$2,563,000 | — | 30 Jun 2023 | |
| Parallax Volatility Advisers, L.P. |
13F
|
Company |
0.21%
|
259,856
|
$2,476,428 | — | 30 Jun 2023 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.2%
|
241,846
|
$2,304,792 | — | 30 Jun 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.19%
|
233,418
|
$2,224,474 | — | 30 Jun 2023 | |
| Two Seas Capital LP |
13F
|
Company |
0.19%
|
232,201
|
$2,212,876 | — | 30 Jun 2023 | |
| 1492 Capital Management LLC |
13F
|
Company |
0.18%
|
222,767
|
$2,122,970 | — | 30 Jun 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.17%
|
212,696
|
$2,026,993 | — | 30 Jun 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.17%
|
210,609
|
$2,007,104 | — | 30 Jun 2023 | |
| Tejara Capital Ltd |
13F
|
Company |
0.13%
|
164,179
|
$1,564,626 | — | 30 Jun 2023 | |
| CITIGROUP INC |
13F
|
Company |
0.12%
|
153,588
|
$1,463,694 | — | 30 Jun 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.12%
|
152,827
|
$1,456,442 | — | 30 Jun 2023 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.12%
|
148,874
|
$1,418,769 | — | 30 Jun 2023 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.12%
|
144,815
|
$1,380,087 | — | 30 Jun 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.12%
|
142,599
|
$1,356,809 | — | 30 Jun 2023 | |
| UBS Group AG |
13F
|
Company |
0.11%
|
139,752
|
$1,331,837 | — | 30 Jun 2023 | |
| PDT Partners, LLC |
13F
|
Company |
0.1%
|
120,578
|
$1,149,108 | — | 30 Jun 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.09%
|
106,750
|
$1,017,328 | — | 30 Jun 2023 |
Institutional Holders of Arcutis Biotherapeutics, Inc. - COMMON STOCK (ARQT) as of Q3 2023
As of 30 Sep 2023,
Arcutis Biotherapeutics, Inc. - COMMON STOCK (ARQT) was held by
131 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
67,159,664 shares.
The largest 10 holders included
Frazier Life Sciences Management, L.P., FMR LLC, Rubric Capital Management LP, JENNISON ASSOCIATES LLC, STATE STREET CORP, BlackRock Inc., Polar Capital Holdings Plc, Bain Capital Life Sciences Investors, LLC, VANGUARD GROUP INC, and MARSHALL WACE, LLP.
This page lists
131
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
135
Q3 2023 holders
131
Holder diff
-4
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 Value $ | Q3 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.